Approval · Notice of Compliance 16995 · 2015
VPRIV: Notice of Compliance 16995
Issued June 15, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16995
- Date
- June 15, 2015
- Company
- Shire Human Genetic Therapies IncLexington, Massachusetts, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Produict monograph update
- Therapeutic class
- Enzyme replacement therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VPRIV | Not yet assigned | — |
Medicinal ingredients
- VELAGLUCERASE ALFA 400 UNIT per VIAL